PMC · DOI:10.3389/fonc.2025.1568579·March 3, 2025
Editorial: Insights, controversies, and new developments in the initial treatment decisions for advanced epithelial ovarian cancer
Jianfeng Guo
Abstract
Linked entities
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Diseases1
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsOvarian cancer diagnosis and treatment · BRCA gene mutations in cancer